|
 |
Chronic Pain
2010 - PI - Leslie Klaff, MD, Ph D (Phase 2a)
A Phase 2A Randomized Double-Blinded, Placebo and Active Controlled Two Cohort Two Doses Cross-Over Multi-Center Clinical Study to Assess Efficacy of a Once Daily Administration of an Investigational Medication for the Treatment of Vasospasm in Primary and Secondary Raynaud’s Phenomenon.
2009 PI – Allen Sussman, MD (Phase II)
A Multicenter, Randomized, Double-Blind, Long Term Study of the Safety of Subcutaneous Administration of An Investigational Medication in Patients with Osteoarthritis of the Knee or Hip
2009 PI – Allen Sussman, MD (Phase IIb)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging, Dose-Loading Study to Evaluate the Efficacy, Safety, and Tolerability of An Investigational Medication as Adjunctive Therapy in Subjects with Inadequately Controlled, Moderate to Severe, Chronic, Low Back Pain.
2008 PI – Barry Bockow, MD (Phase IIIb)
Randomized, Double Blind, Parallel Group, Placebo Controlled Multicenter Study Evaluating the Efficacy of An Investigational Medication BID and Celecoxib 300 mg QD in Patients with Osteoarthritis of the Knee
2007 PI - Leslie Klaff, MD, Ph D (Phase II)
A Multicenter, Randomized, Double Blind, Placebo-Controlled Trial of An Investigational Medicated Tape for Treatment of Chronic Low Back Pain
2006 PI Leslie Klaff, MD, PhD (Phase III)
Phase II Dose-Response Study of a Topical Gel Formulation of Nitroglycerin, MQX-503 in the Treatment of Raynauds Phenomenon
2006 - PI Allen Sussman, MD (Phase III)
A Randomized, Double-Blind, Active Control, Parallel Arm, 90 Day Safety Study of An Investigational Medication Immediate Release (IR) or Oxycodone IR in Subjects with Chronic Pain from Low Back Pain (LBP) or Osteoarthritis (OA) of the Hip or Knee.
2005 PI Allen Sussman, MD (Phase IV)
Double-Blind, Parallel-Group, Randomized, Study of the Efficacy and Safety of Continuous Use of Celecoxib vs. the Usual Use of Celecoxib in the Treatment of Subjects with Chronic Osteoarthritis of the Hip or Knee Who Require An Anti-Inflammatory Medication for Control of the Their Pain
2005 PI Leslie Klaff, MD, PhD (Phase II)
A Multicenter, Two-Phase, Randomized, Enriched, Enrollment, Double-Blind, Vehicle-Controlled Trial of An Investigational Medication Tape for the Treatment of Pain Due to Carpal Tunnel Syndrome and its Symptoms
2004 PI Allan Sussman, MD (Phase IIb)
A 4-Week Randomized, Multicenter, Double-blind, Placebo-and Active-controlled, Parallel group, Forced-titration Phase IIB Study Comparing the Efficacy and Safety of Ascending Doses of an investigational medication and Oxycodone Prolonged release up to 20 mg BID to Placebo in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthrits of the Knee
2003 PI- Allen Sussman, MD (Phase IV)
A randomized, multiple-dose, double-blind, placebo-controlled, parallel-group study comparing the safety and efficacy of an investigational medication and Duragesic in subjects with Non-Malignany Pain.
2003 PI-Allen Sussman, MD (Phase 2)
Safety Evaluation of an investigational medication in Opioid Tolerant Patients
1998 PI - Allen Sussman, MD
A Multicenter, Open-Label Study Evaluating the Safety and Tolerability of Tramadol Hydrochloride Controlled-Release Tables in Patients With Chronic Pain. |
Phase I & Pharmacokinetic Unit